University Of Rochester Ncorp Research Base

This phase 3 trial tests whether bupropion, a drug used for depression and smoking cessation, can reduce fatigue in cancer survivors. About 422 adults who have completed cancer treatment and still have moderate to severe fatigue will receive either bupropion or a placebo. The stu…

This study tests whether a brief behavioral therapy (BBT-CI) or healthy eating education (HEAL) better reduces insomnia in 400 cancer patients receiving treatment. Participants have stage I-IV cancer and report sleep disturbances. The goal is to improve sleep and quality of life.

This study looks at whether exercise can reduce nerve damage symptoms caused by chemotherapy, like pain, numbness, or tingling in hands and feet. About 133 cancer patients who had nerve-damaging chemo in the past 9 months will either exercise or receive standard drug treatment. T…

This study compares how well immune checkpoint inhibitors work in African American/Black and European American/White cancer patients. Researchers will collect blood, saliva, and health information from 2,100 participants to see if there are differences in side effects and treatme…

This study looks at two different ways to provide palliative care—a special type of care that helps with symptoms and stress—to people with advanced cancer and their caregivers. One method uses a virtual learning group, and the other uses one-on-one technical help. The goal is to…